Total Flavonoids from Camellia oleifera Alleviated Mycoplasma pneumoniae-Induced Lung Injury via Inhibition of the TLR2-Mediated NF-κB and MAPK Pathways
Molecules · 13.10.2023 · 28 (20) · 7077
DOI: 10.3390/molecules28207077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 13.10.2023. Verfasst von Nan Ding und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New D…. Hauptthemen laut MEDLINE: Camellia, Lung Injury, Pneumonia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation for Young Scientists of Hunan Province, National Natural Science Foundation of China, the Scientific research project of Hunan Education Department.
Abstract (Originalsprache)
Mycoplasma pneumoniae (M. pneumoniae) is an atypical bacterial pathogen responsible for community-acquired pneumonia primarily among school-aged children and young adults. Camellia oleifera (C. oleifera) has been used as a medicinal and edible plant in China for centuries, the constituents from which possessed various bioactivities. Notably, flavonoids existing in residues of C. oleifera defatted seeds exhibited significant anti-inflammatory activities. In the present study, we investigated the impact of total flavonoids from C. oleifera (TFCO) seed extract on M. pneumoniae pneumonia. TFCO was obtained using multiple column chromatography methods and identified as kaempferol glycosides via UPLC-HRESIMS. In a M. pneumoniae pneumonia mouse model, TFCO significantly reduced the lung damage, suppressed IL-1β, IL-6, and TNF-α production, and curbed TLR2 activation triggered by M. pneumoniae. Similarly, in RAW264.7 macrophage cells stimulated by lipid-associated membrane proteins (LAMPs), TFCO suppressed the generation of proinflammatory cytokines and TLR2 expression. Moreover, TFCO diminished the phosphorylation of IκBα, JNK, ERK, p38, and p65 nuclear translocation in vitro. In conclusion, TFCO alleviated M. pneumoniae-induced lung damage via inhibition of TLR2-mediated NF-κB and MAPK pathways, suggesting its potential therapeutic application in M. pneumoniae-triggered lung inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pathogenic Biology, Hengyang Medical College,…
- Research Lab of Translational Medicine, Hengyang Medical College, University of South China, Hengyang 421001, China.
Förderung
- Natural Science Foundation for Young Scientists of Hunan Province
- National Natural Science Foundation of China
- the Scientific research project of Hunan Education Department
- Scientific research project of Hunan Education Department
- Hunan University students Innovation and Entrepreneurship training program
Zitieren
APA
Ding, N., Lei, A., Shi, Z., Xiang, L., Wei, B., & Wu, Y. (2023). Total Flavonoids from Camellia oleifera Alleviated Mycoplasma pneumoniae-Induced Lung Injury via Inhibition of the TLR2-Mediated NF-κB and MAPK Pathways. Molecules, 28(20), 7077. https://doi.org/10.3390/molecules28207077
Vancouver
Ding N, Lei A, Shi Z, Xiang L, Wei B, Wu Y. Total Flavonoids from Camellia oleifera Alleviated Mycoplasma pneumoniae-Induced Lung Injury via Inhibition of the TLR2-Mediated NF-κB and MAPK Pathways. Molecules. 2023;28(20):7077. doi:10.3390/molecules28207077
BibTeX
@article{Ding2023,
author = {Ding, Nan and Lei, Aihua and Shi, Zhisheng and Xiang, Lin and Wei, Bo and Wu, Yimou},
title = {Total Flavonoids from Camellia oleifera Alleviated Mycoplasma pneumoniae-Induced Lung Injury via Inhibition of the TLR2-Mediated NF-κB and MAPK Pathways},
journal = {Molecules},
year = {2023},
volume = {28},
number = {20},
pages = {7077},
doi = {10.3390/molecules28207077}
}
EUVIMED